Kymera Therapeutics NPS & Customer Reviews | Comparably
Brand Page
Kymera Therapeutics
Marketing or Exec? Claim Your Free Account
Kymera Therapeutics
Rate this Brand

About Kymera Therapeutics' Brand

Kymera Therapeutics is a clinical stage biopharmaceutical company pioneering a transformative new modality, “targeted protein degradation” (TPD), with the ability to pursue targets long considered undruggable and to treat disease in entirely new ways. Our team has developed a proprietary drug discovery engine, Pegasus, to enable the design of highly selective, small molecule protein degraders with potent activity against a broad range of disease indications. We are committed to selecting targets with the broadest possible impact across multiple disease indications with high unmet medical need to realize the full potential of TPD. Kymera is led by an expert team of dedicated scientists and drug hunters, with decades of experience in the foundational areas of targeted protein degradation and drug development.

Kymera Therapeutics NPS

Kymera Therapeutics's Net Promoter Score (NPS) is a -100 with 0% Promoters, 0% Passives, and 100% Detractors. Net Promoter Score tracks whether Kymera Therapeutics's customers would recommend using the product based on a scale of -100 to 100.

Kymera Therapeutics Overall NPS

-100
NPS
0%Promoters
0%Passives
100%Detractors
Kymera Therapeutics Overall NPS

Kymera Therapeutics NPS Trend

-100
-50
0
50
100
Oct 2024
-100
Oct 2024-100

What is NPS

Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"

Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.

Kymera Therapeutics as an Employer

3.4/5

Kymera Therapeutics has a 3.4/5 stars for its overall company culture rated by their employees

  Kymera Therapeutics CEO
bottom
35%
CEO of Kymera Therapeutics

In the Bottom 35% of Similar Sized Companies on Comparably.

Consumer vs. Employees

Kymera Therapeutics scored a -100 for Net Promoter Score and a 10 for Employee Net Promoter Score. NPS gauges how likely a customer of Kymera Therapeutics would recommend the brand to a friend. ENPS measures how likely Kymera Therapeutics employees would recommend working at Kymera Therapeutics to a friend.

Net Promoter Score

-100
NPS Score
0%Promoters
0%Passive
100%Detractors

Employee Net Promoter Score

10
eNPS Score
40%Promoters
30%Passive
30%Detractors

Global Ranking Snapshot

RANKCOMPANYCEOINDUSTRY
1
Costco  Costco CEO
W. Craig Jelinek
Retail
2
Peloton  Peloton CEO
Barry McCarthy
Health and Wellness
3
Chick-fil-A  Chick-fil-A CEO
Dan Cathy
Food and Beverages
4
Netflix  Netflix CEO
Ted Sarandos
Media and Entertainment
5
Apple  Apple CEO
Timothy Cook
Tech
6
Nike  Nike CEO
John Donahoe
Fashion and Beauty
7
Target  Target CEO
Brian Cornell
Retail